Cancer Research Technology (CRT)

• Science & Technology

Cancer Research Technology Pioneer Fund boosts investment in drugs that block cancer defences

The Cancer Research Technology (CRT) Pioneer Fund has today announced its investment in research to develop new drugs. The Cancer Research Technology (CRT) Pioneer Fund has today announced its investment in research to develop new drugs.

5 May 2016

CRT announces license agreement with MSD to develop inhibitors of PRMT5 for cancer and blood disorders

Cancer Research Technology (CRT) – the development and commercialisation arm of Cancer Research UK – has today entered into a license agreement with MSD. Cancer Research Technology (CRT) – the development and commercialisation arm of Cancer Research UK – has today entered into a license agreement with MSD.

27 January 2016

Cancer Research Technology appoints Deborah Harland as non-executive director

Cancer Research Technology (CRT) has today announced the appointment of Dr Deborah Harland to its board of directors. Cancer Research Technology (CRT) has today announced the appointment of Dr Deborah Harland to its board of directors.

9 December 2015

Cancer Research UK, The Lustgarten foundation and Stand Up To Cancer join forces in £8 million pancreatic cancer venture

Cancer Research UK, The Lustgarten Foundation, and Stand Up To Cancer have come together in an international collaboration worth £8 million. Cancer Research UK, The Lustgarten Foundation, and Stand Up To Cancer have come together in an international collaboration worth £8 million.

6 November 2015

• Science & Technology
• Health & Medicine

Cancer Research UK and Cancer Research Technology announce partnership with Monopar Therapeutics to develop new oncology compound

Cancer Research UK, Cancer Research Technology (CRT) and Monopar Therapeutics LLC will take forward an antibody treatment HuATN-658 into clinical trials. Cancer Research UK, Cancer Research Technology (CRT) and Monopar Therapeutics LLC will take forward an antibody treatment HuATN-658 into clinical trials.

9 July 2015

Cancer Research Technology and Medivir collaborate to develop new class of cancer drugs

Cancer Research Technology and Medivir have jointly announced a partnership to develop a new class of drugs. Cancer Research Technology and Medivir have jointly announced a partnership to develop a new class of drugs.

14 April 2015

• Health & Medicine

CRT and Bioinvent expand collaboration with University of Southampton scientists to develop new immunotherapy treatments for cancer

Cancer Research Technology and BioInvent International begin a 2-year research collaboration with antibody researchers at the University of Southampton Cancer Research Technology and BioInvent International begin a 2-year research collaboration with antibody researchers at the University of Southampton

30 March 2015

Bioinvent’s BI-1206 antibody to enter collaborative phase I/II trial funded and conducted by Cancer Research UK, Cancer Research Technology and Leukaemia & Lymphoma Research

Cancer Research UK, Cancer Research Technology and Leukaemia & Lymphoma Research to trial BioInvent's antibody drug for non-Hodgkin lymphoma. Cancer Research UK, Cancer Research Technology and Leukaemia & Lymphoma Research to trial BioInvent's antibody drug for non-Hodgkin lymphoma.

20 January 2015

• Health & Medicine

Cancer Research UK, Cancer Research Technology and Amgen to trial leukaemia immunotherapy drug in other cancers

Cancer Research UK, Cancer Research Technology and Amgen to trial leukaemia immunotherapy drug in patients with soild tuimours. Cancer Research UK, Cancer Research Technology and Amgen to trial leukaemia immunotherapy drug in patients with soild tuimours.

23 December 2014

Three new companies join Cancer Research UK-Abcodia collaboration to identify blood markers for early cancer detection

Three new biomarker companies have been selected to join a CRT-lead initiative to develop blood tests that can detect pre-symotomatic cancer. Three new biomarker companies have been selected to join a CRT-lead initiative to develop blood tests that can detect pre-symotomatic cancer.

10 December 2014

Cancer Research UK to collaborate with AstraZeneca in screening for new cancer medicines at the AstraZeneca MRC UK Centre for Lead Discovery

AstraZeneca and Cancer Research UK have signed a memorandum of understanding to open access to state-of-the-art drug discovery facilities. AstraZeneca and Cancer Research UK have signed a memorandum of understanding to open access to state-of-the-art drug discovery facilities.

28 November 2014

• Science & Technology

BACIT seeks shareholder approval to commit £20m and join CRT Pioneer Fund as a limited partner

BACIT is seeking shareholder approval to permit an investment into the CRT Pioneer Fund, taking the total to £70m. BACIT is seeking shareholder approval to permit an investment into the CRT Pioneer Fund, taking the total to £70m.

26 November 2014